Great wrap-up from European Drug Safety & AI 2026 in Barcelona.It was valuable to engage with industry leaders and peers and share our perspective on the challenges of AI, highlighting the key metrics and evaluation strategy to ensure compliance with regulatory authorities, and to support its transition from concept to [...]
ALWIS attended the 3rd America Drug Safety & AI Conference 2025 – Dec. 9-10, 2025 in San Diego, where our founder, Mr Abdul Rahim presented on key considerations for qualifying AI solutions in Pharmacovigilance. The session highlighted the challenges AI systems pose in life science including pharmacovigilance environments and discussed [...]
ALWIS had a rewarding presence at SCRMP Nexus 2025, where our founder, Mr. Abdul Rahim spoke on the real-world challenges of literature monitoring in pharmacovigilance. The session focused on practical difficulties faced across global and local literature sources, the limitations of automation, and realistic workarounds that help teams balance efficiency [...]
ALWIS will be present at the World Drug Safety Congress Americas 2025, held in Boston from November 4–6, bringing real-time insights into how AI and intelligent automation are reshaping pharmacovigilance. At our booth, attendees can explore our flagship pharmacovigilance solutions, see live product capabilities in action, and gain practical perspectives [...]
ALWIS is participating as a Gold Sponsor at the World Drug Safety Congress Europe 2025 in Amsterdam, engaging with the global drug safety community on the evolving role of technology in pharmacovigilance. You’ll find us at Booth 73, where our team will share practical insights into how AI-driven automation and [...]
Mumbai, India — 19-20th September — ALWIS Solution is proud to announce the successful conclusion of its participation at the DIA India Annual Meeting 2025, one of the most influential global platforms for advancing life sciences and healthcare innovation. Over the course of the event, our team engaged with leading [...]
We are delighted to announce that Abdul Rahim, Founder Director of ALWIS Solutions Ltd, will be a featured speaker at the DIA India Annual Meeting 2025, taking place September 19–20 at the NESCO Center in Mumbai. At this premier life sciences forum, focused on “Innovation Through Integration: Shaping the Future [...]
Introducing CHATBOT — the latest innovation in our platform. Built with conversational AI, CHATBOT helps you move beyond search and manual review. You can now surface relevant insights, identify patterns, and extract key information — all through a seamless, intuitive experience. Experience faster, smarter pharmacovigilance with CHATBOT. [...]
Alwis Group is proud to be a Gold Sponsor at the upcoming WHY Summit – Future of Pharmacovigilance World Tour / World Drug Safety Summit in Basel, Switzerland. This global event will bring together leading experts and innovators to discuss the evolving landscape of drug safety and pharmacovigilance, aligning with [...]
ALWIS Group proudly participated in this high-impact summit focused on advancing drug safety through innovation and collaboration. The two-day event brought together global pharmacovigilance leaders, regulatory experts, and tech pioneers to discuss the evolving landscape of safety monitoring. At the heart of our presence was ReTrans Enterprise, our flagship AI-powered [...]